Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Britta, Stordal"'
Autor:
Britta Stordal, Michelle Harvie, Michael N. Antoniou, Michelle Bellingham, Doris S. M. Chan, Philippa Darbre, Oskar Karlsson, Andreas Kortenkamp, Pamela Magee, Stefano Mandriota, Elisabete Silva, James E. Turner, Laura N. Vandenberg, D. Gareth Evans
Publikováno v:
Cancer Medicine, Vol 13, Iss 18, Pp n/a-n/a (2024)
Abstract The Breast Cancer UK—Breast Cancer Prevention Conference addressed risk from environmental pollutants and health behaviour‐related breast‐cancer risk. Epidemiological studies examining individual chemicals and breast cancer risk have p
Externí odkaz:
https://doaj.org/article/70c3e2894184461e82f75d07e3fce5a2
Publikováno v:
Cancer Medicine, Vol 13, Iss 18, Pp n/a-n/a (2024)
Abstract Introduction Osteosarcoma is the most common primary malignancy of the bone. There is a lack of effective treatments for patients who experience relapsed osteosarcoma. One treatment for relapsed patients is gemcitabine and docetaxel combinat
Externí odkaz:
https://doaj.org/article/4fae7bf35f15447bbe6e2da7f8d925f5
Publikováno v:
Cancer Medicine, Vol 12, Iss 8, Pp 9879-9892 (2023)
Abstract Background Ovarian cancer does not cause many symptoms in the early stages, which is why the majority of cases are of advanced disease. Increasing awareness of ovarian cancer symptoms may lead to earlier diagnosis and improved outcomes. Meth
Externí odkaz:
https://doaj.org/article/8b989dc15fcb4c4f9308a2d0e0d57836
Autor:
Britta Stordal
Publikováno v:
Cancer Medicine, Vol 12, Iss 4, Pp 4616-4625 (2023)
Abstract Women in the UK have a 15% lifetime risk of developing breast cancer. Like other high‐income countries, women in the UK are having children later in life which increases their risk. The risk of breast cancer is reduced by 4.3% for every 12
Externí odkaz:
https://doaj.org/article/3a764cdfadb34a5ba28dd629d612da9c
Autor:
Roshni D. Kalachand, Ciaran O’Riain, Sinead Toomey, Aoife Carr, Kirsten M. Timms, Sharon O’Toole, Stephen Madden, Mark Bates, John J. O’Leary, Noreen Gleeson, Dearbhaile O’Donnell, Liam Grogan, Oscar Breathnach, Angela Farrelly, Britta Stordal, Bryan T. Hennessy
Publikováno v:
Obstetrics & Gynecology Science, Vol 63, Iss 5, Pp 643-654 (2020)
Objective The therapeutic benefits of poly(ADP-ribose) polymerase inhibitors highlight the need to evaluate BRCA1/2 defects in tubal/ovarian cancer (OC). We sought to determine the pattern and disease characteristics associated with tumor BRCA1/2 mut
Externí odkaz:
https://doaj.org/article/6cbb4fc095ea435da4eec3de790092e5
Publikováno v:
MethodsX, Vol 2, Iss C, Pp 8-13 (2015)
Many protocols used for measuring the growth of adherent monolayer cells in vitro are invasive, destructive and do not allow for the continued, undisturbed growth of cells within flasks. Protocols often use indirect methods for measuring proliferatio
Externí odkaz:
https://doaj.org/article/7bf835e83765450397fc15f47d05c8d3
Autor:
Sophie Rae, Cathy Spillane, Gordon Blackshields, Stephen F. Madden, Joanne Keenan, Britta Stordal
The IGROVCDDP cisplatin-resistant ovarian cancer cell line is an unusual model, as it is also cross-resistant to paclitaxel. IGROVCDDP, therefore, models the resistance phenotype of serous ovarian cancer patients who have failed frontline platinum/ta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::307f83fdc3933ccd4157afb4b7bc1d22
https://eprints.mdx.ac.uk/35389/14/13577_2022_Article_744.pdf
https://eprints.mdx.ac.uk/35389/14/13577_2022_Article_744.pdf
Autor:
Britta Stordal
Publikováno v:
Cancer medicineREFERENCES.
Women in the UK have a 15% lifetime risk of developing breast cancer. Like other high-income countries, women in the UK are having children later in life which increases their risk. The risk of breast cancer is reduced by 4.3% for every 12 months of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cec551205e030c6b955b20d1697db73b
https://pubmed.ncbi.nlm.nih.gov/36164270
https://pubmed.ncbi.nlm.nih.gov/36164270
Publikováno v:
Advanced Biology. 7:2200194
Two human osteosarcoma cell lines (MG-63 and HOS-143B) are developed into drug-resistant models using a short-term drug exposure and recovery in drug-free media. Cisplatin, doxorubicin, and methotrexate are used as single agents and in triple combina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37d3f51a64188b78f58d890686c94c66
https://doi.org/10.1002/adbi.202200194
https://doi.org/10.1002/adbi.202200194
Autor:
Charles J d'Adhemar, Cathy D Spillane, Michael F Gallagher, Mark Bates, Katie M Costello, Jacqui Barry-O'Crowley, Kathryn Haley, Niamh Kernan, Ciara Murphy, Paul C Smyth, Ken O'Byrne, Stephen Pennington, Aoife A Cooke, Brendan Ffrench, Cara M Martin, Dearbhaile O'Donnell, Bryan Hennessy, Britta Stordal, Stephen Finn, Amanda McCann, Noreen Gleeson, Tom D'Arcy, Brian Flood, Luke A J O'Neill, Orla Sheils, Sharon O'Toole, John J O'Leary
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e100816 (2014)
The prognosis of epithelial ovarian cancer is poor in part due to the high frequency of chemoresistance. Recent evidence points to the Toll-like receptor-4 (TLR4), and particularly its adaptor protein MyD88, as one potential mediator of this resistan
Externí odkaz:
https://doaj.org/article/208a05f77739491a8afed939f68cee69